Technological Based Rehabilitation on Individuals With Rheumatic Disease

Status Recruiting

Clinical Trial Summary

Affects such as pain, swelling, tenderness, deformities, limitations, strength and function losses, skill and coordination deficiencies in the hand joints, which are frequently seen in rheumatism patients with hand involvement, are included in body structure and function disorders within the framework of International Classification of Function System. Leap Motion Controller is used in hand rehabilitation because it is small in size, low-cost, portable, non-contact, easy to use and provides visual and auditory feedback. The aim of our study is to examine the effect of technology-based rehabilitation on joint range of motion, grip strength, functionality and disease activity in adult individuals with rheumatic disease with hand involvement; and also to compare these effects with the effects of the hand rehabilitation program implemented under the guidance of a physiotherapist and the control group that continues its routine life.

Clinical Trial Description

In the study, 45 adult individuals diagnosed with rheumatic disease with hand involvement will be randomly divided into 3 groups. The first group will be given virtual reality exercises via Leap Motion Controller. Virtual reality exercises will be applied 30 minutes a day, 3 days a week for 8 weeks. To the second group, a conventional hand rehabilitation program will be applied under the supervision of a physiotherapist. The hand rehabilitation program will be applied 30 minutes a day, 3 days a week for 8 weeks. The third group will be the control group, which continues with its routine medications and is not included in any exercise program. After randomization, the individuals' joint range of motion, gross and fine grip strength, functionality, and disease activities will be evaluated. Evaluations will be made twice, at the beginning and at the end of the 8-week program. Disease Activity Score 28 (DAS 28), hand dynamometer, picnometer, Jebsen Hand Function Test, Nine Hole Peg Test, Duruoz Hand Index and Michigan Hand Outcome questionnairre will be used for evaluation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06385574
Study type	Interventional
Source	Akdeniz University
Contact	Ishak Isik, MD
Phone	+90 242 249 00 00
Email	etik.kurul.07@gmail.com
Status	Recruiting
Phase	N/A
Start date	March 15, 2024
Completion date	June 20, 2024

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04976972` - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation	N/A
Completed	`NCT04042792` - Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
Recruiting	`NCT05554029` - Coronaphobia in Rheumatic Diseases	N/A
Completed	`NCT02944448` - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee	Phase 2
Completed	`NCT02694796` - Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy	N/A
Completed	`NCT02269254` - Persona Versus NexGen	N/A
Completed	`NCT02256098` - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA	N/A
Completed	`NCT00642837` - A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets	Phase 4
Active, not recruiting	`NCT04704544` - Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)	N/A
Completed	`NCT05026853` - Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice	N/A
Active, not recruiting	`NCT04631965` - Healthcare Transition of Adolescents With Chronic Health Conditions
Recruiting	`NCT00024479` - Natural History of Rheumatic Diseases in Minority Communities
Completed	`NCT05031104` - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis	N/A
Not yet recruiting	`NCT04567576` - Predictive Factors for COVID-19 in Rheumatology
Completed	`NCT02291471` - Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers	Phase 1
Completed	`NCT01227694` - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis	Phase 1/Phase 2
Recruiting	`NCT01071447` - Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment	N/A
Active, not recruiting	`NCT05618782` - Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee	Phase 2
Active, not recruiting	`NCT05543642` - The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)	Phase 4
Active, not recruiting	`NCT02694185` - Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.